Haematologica. Open access journal of the Ferrata-Storti Foundation, a no profit organization
Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Haematologica. Open access journal of the Ferrata-Storti Foundation, a no profit organization
Open access journal of the Ferrata-Storti Foundation, a non-profit organization
  • Home
  • Current Issue
  • Early view
  • Review Series
  • Archive
  • About Us
    About Haematologica Editorial Team Our Policies Advertising Rights & Permissions Contact
  • Haematologica Award
    How to participate 2025 Winners
  • Submit a Manuscript
    Author Guidelines Reviewer Guidelines Submit and Track Manuscript Track Manuscript submitted before October 1st, 2025
Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Advanced filters

Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia (276 Online Views)

V Callea, F Morabito, F Luise, A Piromalli, M Filangeri, C Stelitano, P Iacopino, F Nobile, M Brugiatelli

The in vitro cytotoxic effect of mitoxantrone in combination with fludarabine or pentostatin in B-cell chronic lymphocytic leukemia (364 Online Views)

F Morabito, I Callea, G Console, C Stelitano, G Sculli, M Filangeri, B Oliva, C Musolino, P Iacopino, M Brugiatelli

Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi (234 Online Views)

F Merli, M Federico, P Avanzini, F Ilariucci, C Stelitano, E Iannitto, M Colombi, D Vallisa, G Santagati, L Picinini

Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL) (208 Online Views)

V Callea, V Clo, F Morabito, L Baldini, C Stelitano, F Narni, P Avanzini, M Brugiatelli, V Silingardi

Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases (331 Online Views)

C Stelitano, F Morabito, MG Kropp, V Callea, F Iuliano, V Oriana, D Levato, F Nobile, S Molica, M Brugiatelli

Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL) (336 Online Views)

G Longo, C Fiorani, S Sacchi, V Callea, M Lombardo, M Federico, C Stelitano, F Angrilli, D Vallisa, PG Gobbi, F Ilariucci, A Frassoldati, M Petrini, V Silingardi

In vitro drug-induced cytotoxicity predicts clinical response to high-dose chlorambucil in B-cell chronic lymphocytic leukemia (618 Online Views)

V Callea, C Stelitano, I Callea, G Console, M Brugiatelli, F Morabito

Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry (291 Online Views)

C Stelitano, L Baldini, C Pieresca, V Callea, F Angrilli, V Clo, G Partesotti, F Merli, L Cavanna, F Morabito, M Federico, M Brugiatelli, V Silingardi

A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL) (427 Online Views)

PG Gobbi, ML Ghirardelli, P Avanzini, L Baldini, G Quarta, C Stelitano, C Broglia, C Loni, V Silingardi, E Ascari

The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas (361 Online Views)

PG Gobbi, ML Ghirardelli, C Cavalli, L Baldini, C Broglia, V Clo, R Berte, F Ilariucci, M Carotenuto, L Piccinini, C Stelitano, G Attardo-Parrinello, E Ascari

Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil (408 Online Views)

F Morabito, M Mangiola, C Stelitano, S Deaglio, V Callea, F Malavasi

Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma (723 Online Views)

F Morabito, M Martino, C Stelitano, E Oliva, M Kropp, G Irrera, G Console, M Fujo, G Messina, S Molica, V Callea, P Iacopino

Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: anecdotal observation or pathogenetic hypothesis for the clinical outcome? (288 Online Views)

F Morabito, M Mangiola, C Stelitano, S Deaglio, V Callea, F Malavasi

Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro (421 Online Views)

F Morabito, M Mangiola, D Rapezzi, S Zupo, BM Oliva, AM Ferraris, M Spriano, E Rossi, C Stelitano, V Callea, G Cutrona, M Ferrarini

In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features (311 Online Views)

F Morabito, C Stelitano, I Callea, M Filangeri, B Oliva, G Sculli, V Callea, F Nobile, M Brugiatelli

The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease (583 Online Views)

A Gallamini, L Rigacci, F Merli, L Nassi, A Bosi, I Capodanno, S Luminari, U Vitolo, R Sancetta, E Iannitto, L Trentin, C Stelitano, S Tavera, A Biggi, A Castagnoli, A Versari, M Gregianin, E Pelosi, P Torchio, A Levis

Prognostic relevance of serum β2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study (2230 Online Views)

Massimo Federico, Cesare Guglielmi, Stefano Luminari, Caterina Mammi, Luigi Marcheselli, Umberto Gianelli, Antonino Maiorana, Francesco Merli, Monica Bellei, Samantha Pozzi, Caterina Stelitano, Antonio Lazzaro, Paolo G. Gobbi, Luca Baldini, Stefania Bergantini, Vittorio Fregoni, Maura Brugiatelli

Secondary malignancies after treatment for indolent non-Hodgkin’s lymphoma: a 16-year follow-up study (2296 Online Views)

Stefano Sacchi, Luigi Marcheselli, Alessia Bari, Raffaella Marcheselli, Samantha Pozzi, Stefano Luminari, Marco Lombardo, Gabriele Buda, Antonio Lazzaro, Paolo G. Gobbi, Caterina Stelitano, Fortunato Morabito, Giovanni Quarta, Maura Brugiatelli

Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells (1082 Online Views)

Giovanna Cutrona, Monica Colombo, Serena Matis, Marina Fabbi, Mauro Spriano, Vincenzo Callea, Ernesto Vigna, Massimo Gentile, Simonetta Zupo, Nicholas Chiorazzi, Fortunato Morabito, Manlio Ferrarini

Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers (1891 Online Views)

Francesco Zaja, Stefano De Luca, Umberto Vitolo, Lorella Orsucci, Alessandro Levis, Flavia Salvi, Chiara Rusconi, Erika Ravelli, Alessandra Tucci, Chiara Bottelli, Monica Balzarotti, Ercole Brusamolino, Maurizio Bonfichi, Stefano A. Pileri, Elena Sabattini, Stefano Volpetti, Chiara Monagheddu, Angelo Vacca, Roberto Ria, Renato Fanin

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi (1655 Online Views)

Michele Merli, Carlo Visco, Michele Spina, Stefano Luminari, Virginia Valeria Ferretti, Manuel Gotti, Sara Rattotti, Valeria Fiaccadori, Chiara Rusconi, Clara Targhetta, Caterina Stelitano, Alessandro Levis, Achille Ambrosetti, Davide Rossi, Luigi Rigacci, Alfonso Maria D’Arco, Pellegrino Musto, Annalisa Chiappella, Luca Baldini, Maurizio Bonfichi, Luca Arcaini

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study (1695 Online Views)

Davide Rossi, Alessio Bruscaggin, Piera La Cava, Sara Galimberti, Elena Ciabatti, Stefano Luminari, Luigi Rigacci, Alessandra Tucci, Alessandro Pulsoni, Giovanni Bertoldero, Daniele Vallisa, Chiara Rusconi, Michele Spina, Luca Arcaini, Francesco Angrilli, Caterina Stelitano, Francesco Merli, Gianluca Gaidano, Massimo Federico, Giuseppe A. Palumbo

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi (1648 Online Views)

Francesco Zaja, Simone Ferrero, Caterina Stelitano, Angela Ferrari, Flavia Salvi, Annalisa Arcari, Gerardo Musuraca, Barbara Botto, Michele Spina, Claudia Cellini, Caterina Patti, Anna M. Liberati, Claudia Minotto, Stefano A. Pileri, Manuela Ceccarelli, Stefano Volpetti, Antonella Ferranti, Daniela Drandi, Elisa Montechiarello, Marco Ladetto, James Carmichael, Renato Fanin

MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients (3445 Online Views)

Maria R. Ambrosio, Stefano Lazzi, Giuseppe Lo Bello, Raffaella Santi, Leonardo Del Porro, Maria M. de Santi, Raffaella Guazzo, Lucia Mundo, Luigi Rigacci, Sofia Kovalchuck, Noel Onyango, Alberto Fabbri, Emanuele Cencini, Pier Luigi Zinzani, Francesco Zaja, Francesco Angrilli, Caterina Stelitano, Maria G. Cabras, Giuseppe Spataro, Roshanak Bob, Thomas Menter, Massimo Granai, Gabriele Cevenini, Kikkeri N. Naresh, Harald Stein, Elena Sabattini, Lorenzo Leoncini

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial (7095 Online Views)

Riccardo Bruna, Fabio Benedetti, Carola Boccomini, Caterina Patti, Anna Maria Barbui, Alessandro Pulsoni, Maurizio Musso, Anna Marina Liberati, Guido Gini, Claudia Castellino, Fausto Rossini, Fabio Ciceri, Delia Rota-Scalabrini, Caterina Stelitano, Francesco Di Raimondo, Alessandra Tucci, Liliana Devizzi, Valerio Zoli, Francesco Zallio, Franco Narni, Alessandra Dondi, Guido Parvis, Gianpietro Semenzato, Francesco Lanza, Tommasina Perrone, Francesco Angrilli, Atto Billio, Angela Gueli, Barbara Mantoan, Alessandro Rambaldi, Alessandro Massimo Gianni, Paolo Corradini, Roberto Passera, Marco Ladetto, Corrado Tarella

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 – VERITAS study (3897 Online Views)

Francesca R. Mauro, Irene Della Starza, Monica Messina, Gianluigi Reda, Livio Trentin, Marta Coscia, Paolo Sportoletti, Lorella Orsucci, Valentina Arena, Gloria Margiotta Casaluci, Roberto Marasca, Roberta Murru, Luca Laurenti, Fiorella Ilariucci, Caterina Stelitano, Donato Mannina, Massimo Massaia, Gian Matteo Rigolin, Lydia Scarfò, Monia Marchetti, Luciano Levato, Monica Tani, Annalisa Arcari, Gerardo Musuraca, Marina Deodato, Piero Galieni, Valeria Belsito Patrizi, Daniela Gottardi, Anna Marina Liberati, Annamaria Giordano, Maria Chiara Molinari, Daniela Pietrasanta, Veronica Mattiello, Andrea Visentin, Candida Vitale, Francesco Albano, Antonino Neri, Lucia Anna De Novi, Maria Stefania De Propris, Mauro Nanni, Ilaria Del Giudice, Anna Guarini, Paola Fazi, Marco Vignetti, Alfonso Piciocchi, Antonio Cuneo, Robin Foà

Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study (4020 Online Views)

Emilio Iannitto, Simone Ferrero, Côme Bommier, Daniela Drandi, Martina Ferrante, Krimo Bouabdallah, Sylvain Carras, Guido Gini, Vincent Camus, Salvatrice Mancuso, Luigi Marcheselli, Angela Ferrari, Michele Merli, Benoit Tessoulin, Caterina Stelitano, Kheira Beldjord, Giovanni Roti, Fabrice Jardin, Barbara Castagnari, Francesca Palombi, Lucile Baseggio, Alexandra Traverse-Glehen, Claudio Tripodo, Anna Marina Liberati, Margherita Parolini, Sara Usai, Caterina Patti, Massimo Federico, Maurizio Musso, Marco Ladetto, Emanuele Zucca, Catherine Thieblemont

Erratum to: Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study (1008 Online Views)

Emilio Iannitto, Simone Ferrero, Côme Bommier, Daniela Drandi, Martina Ferrante, Krimo Bouabdallah, Sylvain Carras, Guido Gini, Vincent Camus, Salvatrice Mancuso, Luigi Marcheselli, Angela Ferrari, Michele Merli, Benoit Tessoulin, Caterina Stelitano, Kheira Beldjord, Giovanni Roti, Fabrice Jardin, Barbara Castagnari, Francesca Palombi, Lucile Baseggio, Alexandra Traverse-Glehen, Claudio Tripodo, Anna Marina Liberati, Margherita Parolini, Sara Usai, Caterina Patti, Massimo Federico, Maurizio Musso, Marco Ladetto, Emanuele Zucca, Catherine Thieblemont

Rethinking the feasibility and safety of venetoclaxobinutuzumab in chronic lymphocytic leukemia: nontraditional factors may play a role in clinical practice (3129 Online Views)

Anna Maria Frustaci, Andrea Galitzia, Mariano Lucignano, Lorena Appio, Jacopo Olivieri, Alessandro Sanna, Claudia Baraté, Fabrizio Pane, Luana Schiattone, Beatrice Casadei, Isacco Ferrarini, Amalia Figuera, Paolo Sportoletti, Giacomo Loseto, Caterina Stelitano, Andrea Visentin, Melania Celli, Francesca Romana Mauro, Massimiliano Palombi, Marta Coscia, Vanessa Innao, Riccardo Moia, Marina Motta, Filomena Russo, Monica Tani, Annalisa Arcari, Elia Boccellato, Chiara Borella, Enrico Capochiani, Angela Ferrari, Massimo Gentile, Roberta Giachetti, Annamaria Giordano, Martina Bullo, Enrico Lista, Luigi Malandruccolo, Maurizio Musso, Marzia Varettoni, Federico Vozella, Francesca Cibien, Michele Merli, Laura Nocilli, Maria Cristina Pasquini, Azzurra Anna Romeo, Valentina Rossi, Gloria Turri, Anna Vanazzi, Marina Cavaliere, Alessandro Gozzetti, Lara Crucitti, Moira Lucesole, Marina Deodato, Annamaria Tomasso, Arianna Zappaterra, Roberta Murru, Caterina Patti, Luca Laurenti, Alessandra Tedeschi

Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi (383 Online Views)

F Merli, M Bertini, S Luminari, R Mozzana, R Berte, M Trottini, C Stelitano, B Botto, M Pizzuti, G Quintana, A De Paoli, M Federico, Intergruppo Italiano Linfomi

Loading...
Searching...
1 - 30 of 30 items
Navigate
  • Home
  • Current issue
  • Early view
  • Archive
  • About Haematologica
  • Editorial Team
  • Our policies
  • Contact
For Authors
  • Author Guidelines
  • Submit Manuscript
  • Track Manuscript
For Reviewers
  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
For Advertisers
  • Information For Advertising
Education
  • Review Articles
  • Guidelines Articles
Privacy
  • Cookie Policy
  • Newsletter Privacy Policy
  • Privacy Policy
More
  • Rights & Permissions

  • Web design
  • Development
Copyright © 2026 by the Ferrata Storti Foundation | Web design → | Development →
ISSN 0390-6078 print | ISSN 1592-8721 online